- Cisco Ups Tandberg Bid, Claims Over 40% Backing
- 'Significant Weakness' Still Ahead: Fed's Hoenig
- BlackRock: Central Banks To Be Net Buyers of Gold
- Stronger Yuan Needed for Global Rebalancing: IMF Chief
- Washington Not Trying to Contain China: Obama
- Japan Third Quarter GDP Jumps; 2010 Growth May Slow
- Quiz: How Much Do You Know About Green?
- JP Morgan to Bid Over $3 Billion for Cazenove Stake
- Buffett: I Haven't Bought AMEX Shares in Years
- Warren Buffett to CNBC: 'I Haven't Bought American Express In Years'
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- U.S. Stocks Rally for the Second Straight Week
- Dollar is Not Plunging—So 'Calm Down': Market Strategist
- Strategists Say Markets Have More Upside — But How Much?
- Hirschhorn: Risk-Averse Traders
- Roginsky: A Funny Thing Happened on the Way to Financial Reform
- This Year's Biggest Thanksgiving Leftover: Cash
- TV Series Inks Unique Deal For Fight
MOST SHARED
- U.S. May Wind Up Green With Envy
- Warren Buffett to CNBC: 'I Haven't Bought American Express In Years'
- Japan Third Quarter GDP Jumps; 2010 Growth May Slow
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- Taking a Page from Obama's Asia Agenda in Investing
- The Cost of Thanksgiving Dinner 2009
- EADS Cautious on Full-Year Forecast after Earnings Dip
- Stronger Yuan Needed for Global Rebalancing: IMF Chief
- Sustainability Indices Sprouting Up
- JP Morgan to Bid Over $3 Billion for Cazenove Stake
Text Size 
A first-of-its-kind study suggests that allergic reactions to the popular vaccine for cervical cancer are rare and can often be overcome.
Australian researchers report in the new issue of the "British Medical Journal" that hypersensitivity to the shots is uncommon and that most girls who do have a reaction can later go on to get the shots with no serious side effects. The doctors recommend that more studies be done, however.
Last year Australia started requiring adolescent schoolgirls to get the vaccine for the human papillomavirus (HPV), the sexually transmitted infection that is the leading cause of cervical cancer. After more than 380,000 doses were administered, 35 girls were identified as having had some kind of reaction. The problems included rash, hives and in two patients a more severe, widespread allergic response.
The BMJ study is being published close on the heels of a recent report out of the U.S. Centers for Disease Control that concluded there's no evidence that Gardasil has serious side effects.
Merck [MRK
Loading...
()
] sells the vaccine, Gardasil, in the United States. GlaxoSmithKline [GSK
Loading...
()
] is awaiting FDA approval on a similar product called Cervarix. The Australian researchers say the Merck shots may have ingredients that could be causing the small number of allergic reactions and that the GSK vaccine, which is made differently, could be an alternative for some girls.
Print
Email
- Where, what, how.
- Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
- For the chief of cable company Comcast, growth has been about making deals – generally very large deals.
- Some companies may start using insurance to shift carbon risk from their balance sheets to maybe... yours?
- The president and founder of Genesis Today wants to improve America’s health, and thinks Wal-Mart can help.
- Switzerland's privacy watchdog is taking legal action to force Google to make changes to its Street View service.
Data is a real-time snapshot *Data is delayed at least 15 minutes